ATE223228T1 - Verwendung von latenz assoziierten peptiden in der herstellung eines medikaments zur verbesserung der wundheilung. - Google Patents

Verwendung von latenz assoziierten peptiden in der herstellung eines medikaments zur verbesserung der wundheilung.

Info

Publication number
ATE223228T1
ATE223228T1 AT98903122T AT98903122T ATE223228T1 AT E223228 T1 ATE223228 T1 AT E223228T1 AT 98903122 T AT98903122 T AT 98903122T AT 98903122 T AT98903122 T AT 98903122T AT E223228 T1 ATE223228 T1 AT E223228T1
Authority
AT
Austria
Prior art keywords
composition
medication
latency
production
wound healing
Prior art date
Application number
AT98903122T
Other languages
English (en)
Inventor
Mark William James Ferguson
Vale Furness
Original Assignee
Renovo Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Renovo Ltd filed Critical Renovo Ltd
Application granted granted Critical
Publication of ATE223228T1 publication Critical patent/ATE223228T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1841—Transforming growth factor [TGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Materials For Medical Uses (AREA)
AT98903122T 1997-02-13 1998-02-13 Verwendung von latenz assoziierten peptiden in der herstellung eines medikaments zur verbesserung der wundheilung. ATE223228T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9702943.3A GB9702943D0 (en) 1997-02-13 1997-02-13 Wound healing
PCT/GB1998/000316 WO1998035695A1 (en) 1997-02-13 1998-02-13 Wound healing

Publications (1)

Publication Number Publication Date
ATE223228T1 true ATE223228T1 (de) 2002-09-15

Family

ID=10807557

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98903122T ATE223228T1 (de) 1997-02-13 1998-02-13 Verwendung von latenz assoziierten peptiden in der herstellung eines medikaments zur verbesserung der wundheilung.

Country Status (12)

Country Link
US (1) US6319907B1 (de)
EP (1) EP1009425B1 (de)
JP (1) JP4307561B2 (de)
AT (1) ATE223228T1 (de)
AU (1) AU728851B2 (de)
CA (1) CA2280873C (de)
DE (1) DE69807710T2 (de)
DK (1) DK1009425T3 (de)
ES (1) ES2181165T3 (de)
GB (1) GB9702943D0 (de)
PT (1) PT1009425E (de)
WO (1) WO1998035695A1 (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6756060B1 (en) * 1996-09-19 2004-06-29 Usbiomaterials Corp. Anti-inflammatory and antimicrobial uses for bioactive glass compositions
AU2001268326A1 (en) * 2000-06-14 2001-12-24 Chanda Zaveri Peptides with physiological activity
US20040037828A1 (en) * 2002-07-09 2004-02-26 Bar-Ilan University Methods and pharmaceutical compositions for healing wounds
US20060258562A1 (en) * 2000-07-31 2006-11-16 Healor Ltd. Methods and pharmaceutical compositions for healing wounds
US20030148924A1 (en) * 2002-07-09 2003-08-07 Tamar Tennenbaum Methods and pharmaceutical compositions of healing wounds
JP2004536018A (ja) * 2000-07-31 2004-12-02 バル・イラン・ユニバーシティ 創傷治療のための方法および薬学的組成物
US20100129332A1 (en) * 2000-07-31 2010-05-27 Tamar Tennenbaum Methods and pharmaceutical compositions for healing wounds
EP1369491A1 (de) 2002-06-05 2003-12-10 Aladar A. Szalay Lichtemittierende Mikroorganismen und Zellen für die Diagnose und Therapie von Krankheiten assoziiert mit Wunden oder entzündetem Gewebe
WO2005016254A2 (en) * 2003-07-16 2005-02-24 The Ohio State University Research Foundation Methods and reagents for treating inflammation and fibrosis
ES2375565T3 (es) * 2003-08-07 2012-03-02 Healor Ltd. Composiciones farmacéuticas y métodos para acelerar la cicatrización de heridas.
WO2007026356A2 (en) * 2005-08-29 2007-03-08 Healor Ltd. Methods and compositions for prevention and treatment of diabetic and aged skin
RU2542471C2 (ru) 2006-11-15 2015-02-20 Коуда Терапьютикс, Инк. Улучшенные способы и композиции для заживления ран
KR20100040912A (ko) * 2007-07-30 2010-04-21 힐로 리미티드 약제학적 조성물 및 관련 방법
PL2205623T3 (pl) * 2007-10-29 2016-09-30 Ochronne tetrapeptydy do pielęgnacji skóry
AU2008343840A1 (en) * 2007-12-21 2009-07-09 Coda Therapeutics, Inc. Use of anti-connexin polynucleotides, peptides or antibodies for the treatment of orthopedic conditions
EP2234656A2 (de) 2007-12-21 2010-10-06 Coda Therapeutics, Inc. Verbesserte medizinische vorrichtungen
EP2252690A2 (de) * 2007-12-21 2010-11-24 Coda Therapeutics, Inc. Verwendung von anti-connexin-43-polynukleotiden zur behandlung abnormaler oder übermässiger narben
US20100172217A1 (en) * 2009-01-08 2010-07-08 Von Bezold Ernst System of Methods and Apparati for Handling and Modifying Information Energy and Matter by Formative Resonance
NZ600583A (en) * 2009-02-24 2013-08-30 Healor Ltd Visfatin therapeutic agents for the treatment of acne and other conditions
EP2599494A1 (de) 2010-01-11 2013-06-05 Healor Ltd. PKC-Inhibitoren zur Behandlung von entzündlichen Erkrankungen
US9387183B2 (en) 2011-12-28 2016-07-12 Kuwait University Method of treating diabetes-related impaired wound healing
WO2016029191A2 (en) 2014-08-22 2016-02-25 Auckland Uniservices Limited Channel modulators
US10232009B1 (en) * 2017-09-29 2019-03-19 Pro Sunfun Biotech Research And Development Co., Ltd. Peptide for promoting wound healing, its composition and method of using the same
US12667586B2 (en) 2023-03-07 2026-06-30 Glaukos Corporation Treatments for ocular surface disorders

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991008291A2 (en) * 1989-11-22 1991-06-13 Genentech, Inc. Latency associated peptide and uses therefor
GB9106678D0 (en) 1991-03-28 1991-05-15 Ferguson Mark W J Wound healing
AU5587094A (en) * 1992-10-26 1994-05-24 Kirin Brewery Company, Limited Method for producing large latent transforming growth factor-beta complexes and large latency associated peptide
US6074840A (en) * 1994-02-18 2000-06-13 The Regents Of The University Of Michigan Recombinant production of latent TGF-beta binding protein-3 (LTBP-3)
EP0968723B1 (de) 1994-03-29 2009-07-01 Renovo Limited Heilung von Wunden oder fibrotischen Krankheiten unter Verwendung von wenigstens einem Agens gegen einen Wachstumsfaktor

Also Published As

Publication number Publication date
HK1025504A1 (en) 2000-11-17
CA2280873C (en) 2010-04-06
CA2280873A1 (en) 1998-08-20
EP1009425B1 (de) 2002-09-04
PT1009425E (pt) 2002-11-29
AU5995398A (en) 1998-09-08
JP2001511797A (ja) 2001-08-14
DE69807710T2 (de) 2003-06-05
DE69807710D1 (de) 2002-10-10
DK1009425T3 (da) 2002-10-14
WO1998035695A1 (en) 1998-08-20
JP4307561B2 (ja) 2009-08-05
GB9702943D0 (en) 1997-04-02
ES2181165T3 (es) 2003-02-16
EP1009425A1 (de) 2000-06-21
AU728851B2 (en) 2001-01-18
US6319907B1 (en) 2001-11-20

Similar Documents

Publication Publication Date Title
DE69807710D1 (de) Verwendung von Latenz Assoziierten Peptiden in der Herstellung eines Medikaments zur Verbesserung der Wundheilung.
DK0585242T3 (da) Sårheling
Su et al. The problem scar
Yarborough Jr Ablation of facial scars by programmed dermabrasion
PT646012E (pt) Cura de feridas e tratamento de perturbacoes fibroticas por tgfbeta-3
EP2322226A3 (de) Lösungen und Verfahren zur Inhibition von Schmerz, Entzündungen und Knorpelabbau
AU1823795A (en) Platelet growth accelerator
DE69625906D1 (de) Dinukleotide zur verwendung in der behandlung von lungenkrankheiten
US4485088A (en) Method of treatment of fibrotic lesions by topical administration of lathyrogenic drugs
EP1289537B1 (de) Verfahren zur behandlung von chronischen geschwüren
ATE368455T1 (de) Verwendung von (+)-tramadol, o-demethyltramadol, o-desmethyl-n-mono-desmethyl-tramadol zur therapie der harninkontinenz
DE59600683D1 (de) Verwendung von Trospiumchlorid zur Herstellung eines Arzneimittels zur Behandlung von Blasenkrankheiten
DE69829202D1 (de) Verwendung von mirtazapine zur herstellung eines medikaments zur behandlung von schlafapnoen
DE69800859D1 (de) Verwendung von Moxonidin zur Behandlung neuropathischer Schmerzen
SE9101840D0 (sv) New medicinal use
DE69733557D1 (de) Endothelin-antagonisten zur behandlung von herzversagen
US20040105897A1 (en) Composition and method for the therapeutic modulation of matrix metalloproteinase
DE69917756D1 (de) Methoden zur behandlung von neurombedingten schmerzen
DE69431430D1 (de) Faktor XIII zur Behandlung von Hautwunden
Pandit et al. The effect on wound healing by a modified fibrin scaffold delivering acidic fibroblast growth factor (FGF-1)
DE69904712D1 (de) Verwendung von deltorphin zur behandlung von zytokin-vermittelter leberschädigung
CA1077837A (en) Hydrolytic enzyme material
DE69732851D1 (de) Verwendung von dextrinsulfat zur behandlung von sehr vasculären tumoren
CN115414524A (zh) 重组人ⅲ型胶原蛋白水凝胶敷料在防治烧伤瘢痕中的应用
DE69509657D1 (de) Verwendung von benzothiophenen zur herstellung eines medikaments zur verminderung der narbenbildung bei der wundheilung

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification